First Time Loading...

Antisense Therapeutics Ltd
ASX:ANP

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
ASX:ANP
Watchlist
Price: 0.084 AUD 1.2% Market Closed
Updated: May 4, 2024

Antisense Therapeutics Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Antisense Therapeutics Ltd
Operating Income Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Antisense Therapeutics Ltd
ASX:ANP
Operating Income
-AU$11.4m
CAGR 3-Years
-24%
CAGR 5-Years
-37%
CAGR 10-Years
-17%
Mayne Pharma Group Ltd
ASX:MYX
Operating Income
-AU$165.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Operating Income
AU$204.9m
CAGR 3-Years
N/A
CAGR 5-Years
102%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Operating Income
-AU$18.3m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-28%
Probiotec Ltd
ASX:PBP
Operating Income
AU$20m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
30%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Operating Income
-AU$26.4m
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Antisense Therapeutics Ltd's Operating Income?
Operating Income
-11.4m AUD

Based on the financial report for Jun 30, 2023, Antisense Therapeutics Ltd's Operating Income amounts to -11.4m AUD.

What is Antisense Therapeutics Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-17%

Over the last year, the Operating Income growth was -96%. The average annual Operating Income growth rates for Antisense Therapeutics Ltd have been -24% over the past three years , -37% over the past five years , and -17% over the past ten years .